Novel Azaindazole Derivatives as HCN2 Modulators for Treating Central Nervous System and Psychiatric Disorders, Namely, Schizophrenia, Autism, and Mood Disorders DOI
Ram W. Sabnis

ACS Medicinal Chemistry Letters, Год журнала: 2025, Номер unknown

Опубликована: Май 9, 2025

Язык: Английский

Novel Azaindazole Derivatives as HCN2 Modulators for Treating Central Nervous System and Psychiatric Disorders, Namely, Schizophrenia, Autism, and Mood Disorders DOI
Ram W. Sabnis

ACS Medicinal Chemistry Letters, Год журнала: 2025, Номер unknown

Опубликована: Май 9, 2025

Язык: Английский

Процитировано

0